| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Protara Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 24,000 | 12 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TARA | Protara Therapeutics, Inc. | 12 Jun 2025 | 1 | $0 | 4 | Director | 13 Jun 2025, 16:05 |
| TARA | Protara Therapeutics, Inc. | 07 Jun 2024 | 1 | $0 | 4 | Director | 10 Jun 2024, 18:00 |
| TARA | Protara Therapeutics, Inc. | 07 Jun 2023 | 1 | $0 | 4 | Director | 08 Jun 2023, 16:10 |
| TARA | Protara Therapeutics, Inc. | 08 Jun 2022 | 1 | $0 | 4 | Director | 09 Jun 2022, 16:10 |
| TARA | Protara Therapeutics, Inc. | 09 Jun 2021 | 1 | $0 | 4 | Director | 10 Jun 2021, 20:08 |